指南与共识消化系统肿瘤

OligoPanc项目:寡转移性胰腺癌多学科专家共识

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.
指南 / 共识 · Lancet Oncol · 2026-01-01

OligoPanc项目采用改良Delphi流程与临床情景案例,汇集多学科专家就寡转移性胰腺导管腺癌的定义、诊断措施与治疗路径达成共识。共识以转移灶数目和受累器官数目为核心定义要素,并明确诊断检查、多学科讨论及系统治疗先于局部巩固治疗等推荐。

要点

  • 寡转移定义为单一器官(肝或肺)不超过3个病灶,可同时性或异时性。
  • 诊断需胸腹三期增强CT及肝细胞特异性对比剂MRI,必要时可考虑PET-CT或MRI。
  • 任何局部巩固治疗前必须先行系统治疗,并需多学科肿瘤委员会评估。

核心结论

  • 专家共识明确寡转移性胰腺导管腺癌以转移灶数目和受累器官数目为核心定义要素,并给出诊断与治疗推荐。

研究设计与样本

  • OligoPanc项目汇集多学科专家组,采用改良Delphi流程和临床情景案例建立共识。

主要发现

  • 单一器官(肝或肺)不超过3个病灶可定义为寡转移性胰腺导管腺癌,可为同时性或异时性。
  • 患者自身因素包括年龄不定义寡转移性疾病,但应在任何治疗决策中予以考虑。

关键数值与推荐

  • 寡转移定义:单一器官(肝或肺)最多3个病灶,可同时性或异时性。
  • 必要诊断:胸腹三期增强CT和肝细胞特异性对比剂肝脏MRI;不明确病例可考虑[18F]氟脱氧葡萄糖-PET CT或MRI。
  • 多学科肿瘤委员会评估必不可少;任何局部巩固治疗(手术、立体定向消融放疗或其他局部消融技术)前必须先行系统治疗。

临床怎么用

  • 建议将所提定义纳入未来临床试验以提高可比性并便于验证。
  • 临床决策应经多学科肿瘤委员会讨论,局部巩固治疗前先行系统治疗。

局限性

  • 原文未报告共识形成过程中的具体专家人数、共识阈值及投票数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these knowledge gaps, the OligoPanc project brought together an interdisciplinary group of experts to establish consensus using a modified Delphi process and clinical vignettes. Participants agreed that the number of metastatic lesions and the number of affected organs are key elements in defining oligometastatic pancreatic ductal adenocarcinoma. Specifically, up to three lesions in a single organ, either the liver or the lung, define oligometastatic pancreatic ductal adenocarcinoma and could be either synchronous or metachronous. Necessary diagnostics include a triple-phase contrast-enhanced CT scan of the chest and abdomen and MRI of the liver with a hepatocyte-specific contrast agent. In unclear cases, [18F]fluorodeoxyglucose-PET CT or MRI can be considered. A multidisciplinary tumour board is essential. Patient-intrinsic factors, including age, do not define oligometastatic disease but should be considered for any treatment decision. Systemic treatment before any local consolidative treatment, including surgery, stereotactic ablative radiotherapy, or other locally ablative techniques, is mandatory. The proposed definition should be incorporated into future trials to improve comparability and enable validation.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Leonhardt CS, Adham M, Bazarbashi S, et al. The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. Lancet Oncol. 2026. PMID: 41785904. doi:10.1016/S1470-2045(25)00714-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。